CHESTGuidelines & Topic Collections2025 ATS Interstitial Lung Abnormalities Clinical Statement

2025 ATS Interstitial Lung Abnormalities Clinical Statement

Recorded: November 18, 2025

As interstitial lung abnormalities are increasingly detected through imaging in diverse patient populations, there is growing uncertainty about their significance and management. In this webinar, members of the CHEST Diffuse Lung Disease and Lung Transplant Network's Interstitial Lung Disease Section provide an overview of the 2025 American Thoracic Society (ATS) clinical statement, clarify key definitions and diagnostic criteria, and discuss practical approaches to integrating these recommendations into clinical practice.


Advertisement



Moderator

Giuliana Cerro-Chiang, MD

Assistant Professor
Yale Interstitial Lung Disease Program
Section of Pulmonary, Critical Care, and Sleep Medicine
Yale University School of Medicine
New Haven, CT


Panelist

Belinda D’souza, MD

Chest Radiologist
NYU Langone Health
New York, NY


Panelist

Lida Hariri, MD, PhD, ATSF

Pathologist
Massachusetts General Hospital
Harvard Medical School
Boston, MA


Panelist

Anna Podolanczuk, MD, MS, ATSF

Pulmonologist
Co-Director of Interstitial Lung Disease Program
Weill Cornell Medicine
New York, NY


Panelist

Ivan Rosas, MD

Section Chief of Pulmonary, Critical Care, and Sleep Medicine
Baylor College of Medicine
Houston, TX


Advertisement

Close

Advertisement